Literature DB >> 15845316

A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys.

Joshua A Lile1, Jason T Ross, Michael A Nader.   

Abstract

The purpose of the present study was to compare the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to cocaine. Rhesus monkeys (n=4) responded under a within-session, exponentially increasing, progressive-ratio (PR) schedule of cocaine reinforcement. Breaking point (BP) for the PR schedule was defined as the final response requirement completed before 2 h had elapsed without an injection delivered. Saline and doses of cocaine (0.003-0.3 mg/kg/injection) and MDMA (0.01-0.56 mg/kg/injection) were substituted for the training dose of cocaine for at least five consecutive sessions. Both cocaine and MDMA functioned as reinforcers, but self-administration of MDMA occurred at fewer doses and a significantly lower peak BP was obtained for MDMA. These data demonstrate that MDMA functions as a reinforcer, although its reinforcing efficacy appears to be less than that of cocaine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15845316     DOI: 10.1016/j.drugalcdep.2004.10.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  25 in total

1.  Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.

Authors:  Melanie Mueller; Amy K Goodwin; Nancy A Ator; Una D McCann; George A Ricaurte
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

Review 2.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

3.  Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.

Authors:  Kevin T Ball; Kelly M Walsh; George V Rebec
Journal:  Pharmacol Biochem Behav       Date:  2007-06-02       Impact factor: 3.533

4.  Tolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats.

Authors:  Kevin T Ball; Mylissa Slane
Journal:  Behav Brain Res       Date:  2014-08-12       Impact factor: 3.332

5.  Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2006-10-25       Impact factor: 4.530

6.  Self-administration and behavioral economics of second-generation synthetic cathinones in male rats.

Authors:  S L Huskinson; J E Naylor; E A Townsend; J K Rowlett; B E Blough; K B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2016-11-28       Impact factor: 4.530

7.  Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys.

Authors:  Matthew L Banks; Jon E Sprague; Paul W Czoty; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2007-09-27       Impact factor: 4.530

8.  Relationship between response rates and measures of reinforcing strength using a choice procedure in monkeys.

Authors:  Matthew L Banks; Robert W Gould; Paul W Czoty; Michael A Nader
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

9.  Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.

Authors:  William E Fantegrossi; Rayna M Bauzo; Daniel M Manvich; Jose C Morales; John R Votaw; Mark M Goodman; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2009-05-07       Impact factor: 4.530

Review 10.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.